Table of Contents

Executive Summary

1 Serum Cancer Biomarkers Market Overview

• 1.1 Product Overview and Scope of Serum Cancer Biomarkers
• 1.2 Serum Cancer Biomarkers Segment by Type
  • 1.2.1 Global Serum Cancer Biomarkers Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Hepatocellular Carcinoma Serum Biomarkers
  • 1.2.3 Lung Cancer Serum Biomarkers
  • 1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
  • 1.2.5 Breast Cancer Serum Biomarkers
  • 1.2.6 Glioblastoma Serum Biomarkers
  • 1.2.7 Others
• 1.3 Serum Cancer Biomarkers Segment by Application
  • 1.3.1 Serum Cancer Biomarkers Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Academic & Research Institutes
  • 1.3.4 Ambulatory Surgical Centers
  • 1.3.5 Others
• 1.4 Global Serum Cancer Biomarkers Market by Region
  • 1.4.1 Global Serum Cancer Biomarkers Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Serum Cancer Biomarkers Market Size
  • 1.5.1 Global Serum Cancer Biomarkers Revenue (2014-2025)
  • 1.5.2 Global Serum Cancer Biomarkers Production (2014-2025)

2 Global Serum Cancer Biomarkers Market Competition by Manufacturers

• 2.1 Global Serum Cancer Biomarkers Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Serum Cancer Biomarkers Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Serum Cancer Biomarkers Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Serum Cancer Biomarkers Production Sites, Area Served, Product Types
• 2.5 Serum Cancer Biomarkers Market Competitive Situation and Trends
  • 2.5.1 Serum Cancer Biomarkers Market Concentration Rate
  • 2.5.2 Serum Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Serum Cancer Biomarkers Production Market Share by Regions

• 3.1 Global Serum Cancer Biomarkers Production Market Share by Regions
• 3.2 Global Serum Cancer Biomarkers Revenue Market Share by Regions (2014-2019)
• 3.3 Global Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Serum Cancer Biomarkers Production
  • 3.4.1 North America Serum Cancer Biomarkers Production Growth Rate (2014-2019)
  • 3.4.2 North America Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Serum Cancer Biomarkers Production
  • 3.5.1 Europe Serum Cancer Biomarkers Production Growth Rate (2014-2019)
  • 3.5.2 Europe Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Serum Cancer Biomarkers Production (2014-2019)
  • 3.6.1 China Serum Cancer Biomarkers Production Growth Rate (2014-2019)
  • 3.6.2 China Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Serum Cancer Biomarkers Production (2014-2019)
  • 3.7.1 Japan Serum Cancer Biomarkers Production Growth Rate (2014-2019)
  • 3.7.2 Japan Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Serum Cancer Biomarkers Consumption by Regions

• 4.1 Global Serum Cancer Biomarkers Consumption by Regions
• 4.2 North America Serum Cancer Biomarkers Consumption (2014-2019)
• 4.3 Europe Serum Cancer Biomarkers Consumption (2014-2019)
• 4.4 China Serum Cancer Biomarkers Consumption (2014-2019)
• 4.5 Japan Serum Cancer Biomarkers Consumption (2014-2019)

5 Global Serum Cancer Biomarkers Production, Revenue, Price Trend by Type

• 5.1 Global Serum Cancer Biomarkers Production Market Share by Type (2014-2019)
• 5.2 Global Serum Cancer Biomarkers Revenue Market Share by Type (2014-2019)
• 5.3 Global Serum Cancer Biomarkers Price by Type (2014-2019)
• 5.4 Global Serum Cancer Biomarkers Production Growth by Type (2014-2019)

6 Global Serum Cancer Biomarkers Market Analysis by Applications

• 6.1 Global Serum Cancer Biomarkers Consumption Market Share by Application (2014-2019)
• 6.2 Global Serum Cancer Biomarkers Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Serum Cancer Biomarkers Business

• 7.1 Roche
  • 7.1.1 Roche Serum Cancer Biomarkers Production Sites and Area Served
  • 7.1.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.1.3 Roche Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Pfizer
  • 7.2.1 Pfizer Serum Cancer Biomarkers Production Sites and Area Served
  • 7.2.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.2.3 Pfizer Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Novartis
  • 7.3.1 Novartis Serum Cancer Biomarkers Production Sites and Area Served
  • 7.3.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.3.3 Novartis Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Abbott
  • 7.4.1 Abbott Serum Cancer Biomarkers Production Sites and Area Served
  • 7.4.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.4.3 Abbott Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 BD
  • 7.5.1 BD Serum Cancer Biomarkers Production Sites and Area Served
  • 7.5.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.5.3 BD Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Merck
  • 7.6.1 Merck Serum Cancer Biomarkers Production Sites and Area Served
  • 7.6.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.6.3 Merck Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Eli Lilly
  • 7.7.1 Eli Lilly Serum Cancer Biomarkers Production Sites and Area Served
  • 7.7.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.7.3 Eli Lilly Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Agilent Technologies
  • 7.8.1 Agilent Technologies Serum Cancer Biomarkers Production Sites and Area Served
  • 7.8.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.8.3 Agilent Technologies Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Boehringer Ingelheim
  • 7.9.1 Boehringer Ingelheim Serum Cancer Biomarkers Production Sites and Area Served
  • 7.9.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.9.3 Boehringer Ingelheim Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 AstraZeneca
  • 7.10.1 AstraZeneca Serum Cancer Biomarkers Production Sites and Area Served
  • 7.10.2 Serum Cancer Biomarkers Product Introduction, Application and Specification
  • 7.10.3 AstraZeneca Serum Cancer Biomarkers Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Bristol-Myers Squibb
• 7.12 Novo Nordisk
• 7.13 Allergan
• 7.14 Gilead

8 Serum Cancer Biomarkers Manufacturing Cost Analysis

• 8.1 Serum Cancer Biomarkers Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Serum Cancer Biomarkers
• 8.4 Serum Cancer Biomarkers Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Serum Cancer Biomarkers Distributors List
• 9.3 Serum Cancer Biomarkers Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Serum Cancer Biomarkers Market Forecast

• 11.1 Global Serum Cancer Biomarkers Production, Revenue Forecast
  • 11.1.1 Global Serum Cancer Biomarkers Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Serum Cancer Biomarkers Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Serum Cancer Biomarkers Price and Trend Forecast (2019-2025)
• 11.2 Global Serum Cancer Biomarkers Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Serum Cancer Biomarkers Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Serum Cancer Biomarkers Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Serum Cancer Biomarkers Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Serum Cancer Biomarkers Production, Revenue Forecast (2019-2025)
• 11.3 Global Serum Cancer Biomarkers Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Serum Cancer Biomarkers Consumption Forecast (2019-2025)
  • 11.3.2 Europe Serum Cancer Biomarkers Consumption Forecast (2019-2025)
  • 11.3.3 China Serum Cancer Biomarkers Consumption Forecast (2019-2025)
  • 11.3.4 Japan Serum Cancer Biomarkers Consumption Forecast (2019-2025)
• 11.4 Global Serum Cancer Biomarkers Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Serum Cancer Biomarkers Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.

The global Serum Cancer Biomarkers market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Serum Cancer Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Serum Cancer Biomarkers market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others

Segment by Application
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others